Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Abizaid

Showing results (201-210 of 306) with videos related to

Pageof 31
Sort By:
European Heart Journal|May 19, 2016
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialMichael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
JACC. Cardiovascular Interventions|August 6, 2018
Very Long Term Follow-Up After Percutaneous Balloon Mitral ValvuloplastyRafael A Meneguz-Moreno, J Ribamar Costa, Nisia L Gomes, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisStephen G Ellis, Giuseppe Steffenino, Dean J Kereiakes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
Open Heart|April 19, 2019
Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II studyJo Krogsgaard Simonsen, Emil Nielsen Holck, Didier Carrié, et al.
Circulation. Cardiovascular Interventions|July 22, 2024
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk PatientsS Chris Malaisrie, Mayra Guerrero, Charles Davidson, et al.
Circulation|February 6, 2004
Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trialAurea J Chaves, Amanda G M R Sousa, Luiz A Mattos, et al.
The International Journal of Cardiovascular Imaging|March 5, 2013
Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomographyRodolfo Staico, Marco A Costa, Daniel Chamié, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 31, 2008
EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesionsJ Ribamar Costa, Alexandre Abizaid, Fausto Feres, et al.
The American Journal of Cardiology|June 27, 2021
Seattle Angina Pectoris Questionnaire and Canadian Cardiovascular Society Angina Categories in the Assessment of Total Coronary Atherosclerotic BurdenWelingson Vanucci Negreiros Guimarães, Pedro Felipe Gomes Nicz, Hector M Garcia-Garcia, et al.
Pageof 31

Showing results (201-210 of 306) with videos related to

Sort By:
Pageof 31
European Heart Journal|May 19, 2016
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialMichael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
JACC. Cardiovascular Interventions|August 6, 2018
Very Long Term Follow-Up After Percutaneous Balloon Mitral ValvuloplastyRafael A Meneguz-Moreno, J Ribamar Costa, Nisia L Gomes, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisStephen G Ellis, Giuseppe Steffenino, Dean J Kereiakes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
Open Heart|April 19, 2019
Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II studyJo Krogsgaard Simonsen, Emil Nielsen Holck, Didier Carrié, et al.
Circulation. Cardiovascular Interventions|July 22, 2024
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk PatientsS Chris Malaisrie, Mayra Guerrero, Charles Davidson, et al.
Circulation|February 6, 2004
Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trialAurea J Chaves, Amanda G M R Sousa, Luiz A Mattos, et al.
The International Journal of Cardiovascular Imaging|March 5, 2013
Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomographyRodolfo Staico, Marco A Costa, Daniel Chamié, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 31, 2008
EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesionsJ Ribamar Costa, Alexandre Abizaid, Fausto Feres, et al.
The American Journal of Cardiology|June 27, 2021
Seattle Angina Pectoris Questionnaire and Canadian Cardiovascular Society Angina Categories in the Assessment of Total Coronary Atherosclerotic BurdenWelingson Vanucci Negreiros Guimarães, Pedro Felipe Gomes Nicz, Hector M Garcia-Garcia, et al.
Pageof 31